Clinical Trial Update: TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell Carcinoma [Phase 2, Phase 3]

View source ↗

Summary

A completed phase 2/3 trial evaluating TPF induction chemotherapy for locally advanced resectable oral squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Squamous Cell Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Stage III Oral Cavity Squamous Cell Carcinoma, Stage IVA Oral Cavity Squamous Cell Carcinoma | Phase 2, Phase 3 | Status: COMPLETED